An antibiotic used to treat infective diarrhea could be an effective drug for a type of inflammatory bowel disease, a new ...

The Levy family is excited to be recognized as the 2025 New England Take Steps Honored Family, and Soliel as the Honored Hero ...

While the rising incidence is due in part to environmental factors including ultra-processed foods and smoking, the ...

Eli Lilly has announced results from the VIVID-2 open-label extension study, showing that most patients with moderately to ...

Older adults with moderate to severe IBD can achieve remission with JAK inhibitors, according to a study presented at Crohn’s & Colitis Congress.

Better cardiovascular safety and lower risk of all-cause mortality was observed among older adult patients with IBD who received ustekinumab vs vedolizumab.

"Eli Lilly reports positive data from trial of Omvoh for Crohn’s disease" was originally created and published by Clinical ...

A preliminary modeling study suggests that four variables accessible at discharge could predict the risk for 90-day ...

Kendall Markovic was a leader on and off the field when Hutchinson’s girls and boys soccer teams played host to Rockford Tuesday. The senior co-captain started as a mid-fielder, plus helped ...

INDIANAPOLIS - Eli Lilly and Company (NYSE: NYSE:LLY), a pharmaceutical giant with a market capitalization of $783.7 billion ...

Eli Lilly And Cao (NYSE:LLY) announced the results from the VIVID-2 open-label extension study of Omvoh (mirikizumab-mrkz).

The composite of patient-reported clinical response and endoscopic response was significantly greater in mirikizumab versus ...